Login
$BHR
$1.39 -$0.02 (1.42%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Investments in hotel properties, gross
Accumulated depreciation
Investments in hotel properties, net
Cash and cash equivalents
Restricted cash
Investment in securities (amortized cost of $0 and $42,279, respectively)
Accounts receivable, net of allowance of $129 and $113, respectively
Inventories
Note receivable
Prepaid expenses
Deposit paid to Ashford Inc.
Deferred costs, net
Investment in unconsolidated entity
Derivative assets
Operating lease right-of-use assets
Other assets
Intangible assets, net
Due from third-party hotel managers
Ashford Inc.
Related Party
Nonrelated Party
Assets held for sale
Total assets
LIABILITIES AND EQUITY
Liabilities:
Indebtedness, net
Accounts payable and accrued expenses
Redeemable preferred stock redemptions payable
Series E Preferred Stock
Series M Preferred Stock
Total redeemable preferred stock redemptions payable
Dividends and distributions payable
Due to related parties and nonrelated parties
Ashford Inc.
Related Party
Nonrelated Party
Operating lease liabilities
Other liabilities
Derivative liabilities
Liabilities associated with assets held for sale
Total liabilities
Series preferred stock
Series B Preferred Stock
Series E Preferred Stock
Series M Preferred Stock
Redeemable noncontrolling interests in operating partnership
Equity:
Preferred stock, $0.01 par value, 80,000,000 shares authorized:
8.25% Series D cumulative preferred stock, 1,600,000 shares issued and outstanding at June 30, 2026 and December 31, 2025
Common stock, $0.01 par value, 250,000,000 shares authorized, 68,679,318 and 68,219,432 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders’ equity of the Company
Noncontrolling interest in consolidated entities
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support